News items Full blood count COVID-19 patients predict disease severity
21 December 2020

International research led by the Radboud university medical center shows that a full blood count of COVID-19 patients predicts fairly accurately whether the infection will have a complicated course or not. This makes it easier for healthcare providers to estimate the expected clinical picture. This study, conducted in eleven hospitals, has now been published in the scientific journal eLife.

In patients presenting to hospitals with a COVID-19 infection, full blood count analysis (hemocytometry) are commonly performed at the emergency department and during hospitalization. COVID-19 is accompanied by specific changes in the circulating blood cells that are analyzed by a full blood count. These changes in the blood cells, especially those that can be identified using new techniques, are used to create an algorithm with a predictive value. The developed algorithm appears to predict the course of COVID-19 better than the value of the individual blood cells, as used so far. The reliability increases to 93% after six days.

Predicting disease progression

Using data generated by full blood count measurements, the researchers wanted to know whether it is possible to predict whether a hospitalized COVID-19 patient will become seriously ill and needs treatment at the Intensive Care. For this purpose, they examined the data of 982 adult patients in eleven different hospitals across Europe. And this turned out to be possible: specific changes in the circulating blood cells of COVID-19 patients proved to be of use as indicators whether a serious course of events was expected. New laboratory techniques make it possible to detect whether immune cells in the blood are activated and it turned out that especially these activated cells were more present of COVID-19 patients with a severe course, including during the early course of the disease. In a second study population the researchers were able to confirm the value of the prognostic score.

Cheap and available

Internist-infectiologist and principal investigator André van der Ven of Radboud university medical center explains: "A full blood count is a fully automated, inexpensive, immediately available measurement and one of the most requested laboratory determinations in the world. Full blood count measurements are also routinely requested from COVID-19 patients who present to the hospital. By using certain techniques, the character of certain blood cells can be better determined and by using these new techniques, we have been able to develop a reliable prognostic score. This score gives a good insight into whether a serious course of events can be expected and can help healthcare professionals to make treatment decisions".

About the study

Publication in eLife: A novel haemocytometric COVID-19 prognostic score developed and validated in an observational multicentre European hospital-based study – Joachim Linssen, Anthony Ermens, Marvin Berrevoets, Michela Seghezzi, Giulia Previtali, Simone van der Sar-van der Brugge, Henk Russcher, Annelies Verbon, Judith Gillis, Jürgen Riedl, Eva de Jongh, Jarob Saker, Marion Münster, Imke CA Munnix, Anthonius Dofferhof, Volkher Scharnhorst, Heidi Ammerlaan, Kathleen Deiteren, Stephan JL Bakker, Lucas Joost Van Pelt, Yvette Kluiters-de Hingh, Mathie PG Leers, Andre J van der Ven.

More information

Pauline Dekhuijzen

wetenschaps- en persvoorlichter

send an email

Related news items

Real-time dialogue with a dreaming person is possible

25 February 2021

Dreams take us to what feels like a different reality. They also happen while we're fast asleep. So, you might not expect that a person in the midst of a vivid dream would be able to perceive questions and provide answers to them. But a new international study shows that, in fact, they can.

read more

Vulnerable Nijmegen citizens less likely to visit GP physically due to corona

23 February 2021

The COVID-19 pandemic in 2020 in Nijmegen and the surrounding area led to a substantial decrease in GP consultations for patients with chronic physical health problems.

read more

SATB1 - Three classes of mutations and their unique rare diseases

18 February 2021

Recent advances in DNA sequencing technologies have made it possible to uncover the causes of multiple rare diseases. A new collaborative study describes how three classes of mutation within the same gene result in different neurodevelopmental disorders.

read more

New Physical, Mental, and Cognitive Problems 1-year Post-ICU

18 February 2021

Half of the Intensive Care Unit (ICU) survivors suffer from new physical, mental and/or cognitive problems one year after ICU admission. This is evident from the large-scale MONITOR-IC study led by the Radboudumc.

read more

Less inflammation with a traditional Tanzanian diet than with a Western diet

18 February 2021

Study shows differences between western and traditional diet.

read more

Trained immunity: a tool for reducing susceptibility to and the severity of SARS-CoV-2 infection

17 February 2021

In a review in Cell Mihai Netea, Frank van de Veerdonk, Reinout van Crevel and Jorge Dominguez Andres propose that induction of trained immunity by whole-microorganism vaccines may represent an important tool for reducing susceptibility to and severity of SARS-CoV-2.

read more